A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of six months treatment with the tyrosine kinase inhibitor of STI571 for the treatment of pulmonary arterial hypertension. A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of six mont ...
A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of six months treatment with the tyrosine kinase inhibitor of STI571 for the treatment of pulmonary arterial hypertension. A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of six mont ...